Group II mGlu receptor agonists inhibit behavioural and electrophysiological effects of DOI in mice
Introduction
It has been postulated that brain 5-HT2A receptors may be involved in the pathogenesis and treatment of psychiatric disorders such as anxiety, depression and psychosis Deakin, 1988, Schmidt et al., 1995. There is a good correlation between hallucinogenic potency of drugs and their affinity for 5-HT2A receptors Glennon et al., 1984, Titeler et al., 1988. Furthermore, 5-HT2A antagonists block the psychotomimetic effects of hallucinogens in humans (Vollenweider et al., 1998). Therefore, it has been hypothesized that the 5-HT2A receptor in the frontal cortex may be the primary site of action of hallucinogens and may by critically involved in the actions of many atypical antipsychotics (Aghajanian and Marek, 1999). Electrophysiological studies in rat cortical slices demonstrated that serotonin, as well as hallucinogens lysergic acid diethylamide (LSD) and (±)1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), induces a robust increase in spontaneous excitatory postsynaptic potentials (EPSPs) in layer V pyramidal neurons (Aghajanian and Marek, 1997). This effect is mediated via 5-HT2A receptors and may underlie the hallucinogenic action of 5-HT2A receptor agonists Abi-Saab et al., 1999, Aghajanian and Marek, 1999. In behavioral studies in rodents, 5-HT2A agonists induce head twitches, and this behaviour provides an experimental model to study 5-HT2 receptor function in the brain Green et al., 1983, Darmani et al., 1990.
There is growing evidence that interactions of excitatory amino acids (EAAs) and serotonin may be important for the control of many brain activities and play an important role in a wide range of behaviours Arvanov et al., 1999, Martin et al., 1998, Kim et al., 1999, Loscher and Honack, 1993, Płaźnik et al., 1994, Płaźnik et al., 1997. Electrophysiological studies have shown that serotonin exerts various modulatory effects on glutamatergic transmission, depending on the brain region studied and serotonin receptor subtype involved Marek and Aghajanian, 1998, Schmitz et al., 1998. On the other hand, glutamate, via stimulation of metabotropic glutamate (mGlu) receptors, can also modulate some effects of 5-HT receptor activation. Aghajanian and Marek (1997) have demonstrated that a nonselective mGlu receptor agonist, 1-Aminocyclopentane-1,3-dicarboxylic acid (ACPD), suppresses the increase in frequency of spontaneous EPSPs and excitatory postsynaptic currents (EPSCs) induced in rat cerebral cortex layer V pyramidal cells by 5-HT2A receptor activation. Recently, Marek et al. (1999) and Aghajanian and Marek (1999), using intracellular recording from layer V pyramidal cells in the rat medial prefrontal cortex, provided evidence that two selective Group II mGlu agonists, (+)-2-aminobicyclo [3,1,0] hexane-2,6-dicarboxylic acid (LY354740) and (−)2-oxa-4-aminobicyclo [3,1,0] hexane-2,6-dicarboxylic acid (LY379268), also suppressed the increase in EPSCs induced by 5-HT. Furthermore, the mGlu 2/3 antagonist, (2S,1′S,2′S)-2-(9-xantyhylmethyl)-2-(2′-carboxycyclopropyl)glycine (LY341495), blocked the suppressant effect of LY354740 on the 5-HT-induced EPSCs. LY341495 (by blocking mGlu2/3 receptors) was also able to enhance the frequency and amplitude of spontaneous EPSCs induced by 5-HT (through activation of the 5-HT2A receptor) (Marek et al., 1999), suggesting that endogenous glutamate released by activation of 5-HT2A receptors can activate presynaptic inhibitory Group II mGluR receptors. In parallel to these electrophysiological data, Gewirtz and Marek (2000) demonstrated that administration of LY354740 suppressed DOI-induced head twitches in rats.
In our experiments, we confirmed and extended those findings to mice. We investigated the action of potent and selective Group II mGlu receptor agonists LY354740 and LY379268 on DOI-induced head twitches in mice. Additionally, we studied the effect of LY379268 on DOI-induced spontaneous EPSPs using intracellular and patch-clamp recordings in layer V cortical cells in the mouse frontal cortex.
Section snippets
Animals and housing
The Animal Care and Use Committee at the Institute of Pharmacology approved all experimental procedures. The experiments were carried out on mice (male Albino-Swiss, 24–26 or 20 g for electrophysiology). The animals were kept at an ambient temperature of 20±1 °C and had free access to food (standard laboratory pellets) and tap water before the experiment.
Head twitch test
In order to habituate mice to the experimental environment, each animal was randomly transferred to a 12 cm (diameter)×20 cm (height) glass
DOI-induced head twitches
Ketanserin used as a positive control in our study, produced a dose-dependent decrease (by 90% after the highest dose) in the number of head twitches [F(3,32)=33,389, P<.01] (Fig. 1A). The Group II mGlu receptor agonists LY354740 (0.025–1 mg/kg) significantly [F(7,59)=10.152, P<.001] decreased DOI-induced head twitches (Fig. 1B). The maximal inhibition (by 64%) occurred after a dose of 0.1 mg/kg. The dose–response curve to LY354740 was bell-shaped so that the compound at a dose of 5 mg/kg was
Discussion
Recently discovered, selective, potent and systemically active agonists of Group II mGlu receptors show a wide variety of effects of possible clinical importance. It has been shown in animal studies that agonists of Group II mGlu receptors exhibit anxiolytic-like effects Helton et al., 1998, Kłodzińska et al., 1999, exhibit antiaddictive effects Helton et al., 1997, Kłodzińska et al., 1999, inhibit tolerance to analgesic effects of morphine (Popik et al., 2000), and possess antiseizure activity
Acknowledgements
The study was supported by the Institute of Pharmacology, Polish Academy of Sciences. The authors are grateful to Dr. D.D. Schoepp from Eli Lilly, Indianapolis, IN, for the generous gift of LY354740 and LY379268.
References (42)
- et al.
5-HT2 receptor regulation of extracellular GABA levels in the prefrontal cortex
Neuropsychopharmacology
(1999) - et al.
Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells
Neuropharmacology
(1997) - et al.
Serotonin model of schizophrenia: emerging role of glutamate mechanisms
Brain Res Brain Res Rev
(2000) - et al.
Pharmacological characterization of ear-scratch response in mice as a behavioral model for selective 5-HT2-receptor agonists and evidence for 5-HT1B– and 5-HT2–receptor interactions
Pharmacol, Biochem Behav
(1990) 5HT2 receptors, depression and anxiety
Pharmacol, Biochem Behav
(1988)- et al.
Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors
Neuropsychopharmacology
(2000) - et al.
Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents
Life Sci
(1984) - et al.
Inhibition of 5-hydroxytryptamine-mediated behaviour by the putative 5-HT2 antagonist pirenperone
Neuropharmacology
(1983) - et al.
LY354740: a metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in rats
Neuropharmacology
(1997) - et al.
Potential anti-anxiety, anti-addictive effects of LY354740, a selective group II glutamate metabotropic receptors agonist in animal models
Neuropharmacology
(1999)
Effects of the novel 5-HT1A receptor antagonist, (+)-WAY 100135, on stereotyped behaviour induced by the NMDA receptor antagonist dizocilpine in rats
Eur J Pharmacol
Pharmacology of metabotropic glutamate receptors at the mossy fiber synapses of the guinea pig hippocampus
Neuropharmacology
The electrophysiology of prefrontal serotonin systems: therapeutic implications for mood and psychosis
Biol Psychiatry
The behavioral effects of NMDA antagonists in serotonin depleted rats
Pharmacol, Biochem Behav
The role of 5-HT2A receptors in antipsychotic activity
Life Sci
Pharmacological agents acting at subtypes of metabotropic glutamate receptors
Neuropharmacology
LY354740 affects startle responding but not sensorimotor gating or discriminative effects of phencyclidine
Eur J Pharmacol
Metabotropic glutamate group II receptors are responsible for the depression of synaptic transmission induced by ACPD in the dentate gyrus
Eur J Pharmacol
Serotonin–glutamate interactions: a new target for antipsychotic drugs
Neuropsychopharmacology
A pre- and postsynaptic modulatory action of 5-HT and the 5-HT2A, 2C receptor agonist DOB on NMDA-evoked responses in the rat medial prefrontal cortex
Eur J Neurosci
The metabotropic glutamate 2/3 receptor agonists drugs. LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats
J Pharmacol Exp Ther
Cited by (90)
G<inf>s</inf> signaling pathway distinguishes hallucinogenic and nonhallucinogenic 5-HT<inf>2A</inf>R agonists induced head twitch response in mice
2022, Biochemical and Biophysical Research CommunicationsCortical influences of serotonin and glutamate on layer V pyramidal neurons
2021, Progress in Brain ResearchSerotonin and schizophrenia
2020, Handbook of Behavioral NeuroscienceDepression and schizophrenia viewed from the perspective of amino acidergic neurotransmission: Antipodes of psychiatric disorders
2019, Pharmacology and Therapeutics